HomeBUSINESS
BUSINESS

Will Symbicort and Adoair Face Generic Entries This Year? Trade Group Has Seen High Hurdle for Inhaler Drugs
(Jan.11.2018)

As 2018 rolled in, industry watchers are keeping a close eye on whether generic contenders will hit Symbicort (budesonide + formoterol) and Adoair (fluticasone + salmeterol), major respiratory treatments by AstraZeneca and GlaxoSmithKline, this year. Despite these drugs being potentially lucrative targets, a Japanese generic trade group has stressed high development hurdles for such inhaler medications ...
(LOG IN FOR FULL STORY)

News Calendar